Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.33 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CHKA | P35790 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20600843 | 0.83 | HSP90AA1 (0.41) | HSP90AA1HSP90AB1 | |
| SCHEMBL13737310 | 0.83 | CYP3A4 (0.31) | ALDH1A1 | |
| SCHEMBL13735952 | 0.76 | TLR8 (0.36) | ALDH1A1 | |
| SCHEMBL578224 | 0.75 | IDH1 (0.37) | — | |
| SCHEMBL27076920 | 0.73 | HTR1A (0.31) | — | |
| SCHEMBL73269 | 0.69 | LOXL2 (0.35) | TRPV4CA2CHKA | |
| SCHEMBL3291771 | 0.67 | IDH1 (0.39) | HSP90AA1HSP90AB1TRPV4CA2CHKA | |
| SCHEMBL6137289 | 0.65 | IDH1 (0.36) | HSP90AA1HSP90AB1ALDH1A1 | |
| SCHEMBL6266188 | 0.65 | MEN1 (0.35) | HSP90AA1HSP90AB1 | |
| SCHEMBL3291350 | 0.65 | CES2 (0.44) | HSP90AA1HSP90AB1CA2CHKAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3790390-A1 | METHODS OF APPLYING ONE OR MORE CERTAIN HETEROARYL-1,2,4-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS TO CONTROL DAMAGE ON PLANTS, PROPAGATION MATERIAL THEREOF, AND PLANT DERIVED PRODUCTS | Syngenta Crop Protection AG (CH) | 2021-03-17 | — | — | EP | claimed |
| US-20210068395-A1 | METHODS OF APPLYING ONE OR MORE CERTAIN HETEROARYL-1,2,4-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS TO CONTROL DAMAGE ON PLANTS, PROPAGATION MATERIAL THEREOF, AND PLANT DERIVED PRODUCTS | SYNGENTA CROP PROTECTION AG (CH) | 2021-03-11 | — | — | US | claimed |
| EP-3761791-A1 | USE OF HETEROARYL-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS AS PESTICIDES IN PLANT PROTECTION | Bayer Aktiengesellschaft (DE) | 2021-01-13 | — | — | EP | claimed |
| US-20200404919-A1 | USE OF HETEROARYL-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS AS PESTICIDES IN PLANT PROTECTION | BAYER AKTIENGESELLSCHAFT (DE) | 2020-12-31 | — | — | US | claimed |
| EP-3452460-B1 | HETEROARYL-1,2,4-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS FOR CONTROLLING ECTOPARASITES | ELANCO TIERGESUNDHEIT AG (CH) | 2020-02-12 | — | — | EP | claimed |
| WO-2019215198-A1 | METHODS OF APPLYING ONE OR MORE CERTAIN HETEROARYL-1,2,4-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS TO CONTROL DAMAGE ON PLANTS, PROPAGATION MATERIAL THEREOF, AND PLANT DERIVED PRODUCTS | SYNGENTA CROP PROTECTION AG (CH) | 2019-11-14 | — | — | WO | claimed |
| WO-2019170626-A1 | USE OF HETEROARYL-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS AS PESTICIDES IN PLANT PROTECTION | BAYER AKTIENGESELLSCHAFT (DE) | 2019-09-12 | — | — | WO | claimed |
| US-10287276-B2 | Heteroaryl-1,2,4-triazole and heteroaryl-tetrazole compounds for controlling ectoparasites | ELANCO TIERGESUNDHEIT AG (CH) | 2019-05-14 | — | — | US | claimed |
| EP-3452460-A1 | HETEROARYL-1,2,4-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS FOR CONTROLLING ECTOPARASITES | Elanco Tiergesundheit AG (CH) | 2019-03-13 | — | — | EP | claimed |
| US-20180186778-A1 | HETEROARYL-1,2,4-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS FOR CONTROLLING ECTOPARASITES | ELANCO TIERGESUNDHEIT AG (CH) | 2018-07-05 | — | — | US | claimed |
| US-9029399-B2 | 17α-hydroxylase/C17,20-lyase inhibitors | NOVARTIS AG (CH) | 2015-05-12 | — | — | US | claimed |
| WO-2014131837-A1 | ISOXALINE DERIVATIVES FOR USE IN COTTON PLANTS | SYNGENTA PARTICIPATIONS AG (CH) | 2014-09-04 | — | — | WO | claimed |
| US-20140228386-A1 | 17a-HYDROXYLASE/C17,20-LYASE INHIBITORS | NOVARTIS AG (CH) | 2014-08-14 | — | — | US | claimed |
| EP-2702052-A1 | 17ALPHA-HYDROXYLASE/C17,20-LYASE INHIBITORS | Novartis AG (CH) | 2014-03-05 | — | — | EP | claimed |
| WO-2012149413-A1 | 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS | NOVARTIS AG (CH) | 2012-11-01 | — | — | WO | claimed |
| US-8158560-B2 | Insecticidal arylpyrroline compounds | BAYER CROPSCIENCE AG (DE) | 2012-04-17 | — | — | US | claimed |
| US-20110118319-A1 | Insecticidal Arylpyrroline Compounds | BAYER CROPSCIENCE AG (DE) | 2011-05-19 | — | — | US | claimed |
| US-7772267-B2 | or other nuclear hormone receptors inhibitors; 4-(7-Hydroxy-1,3-dioxo-tetrahydropyrrolo[1,2-c]imidazol-2-yl)-5,6,7,8-tetrahydronaphthalene-1-carbonitrile; age-related diseases: sarcopenia, muscular atrophy, lipodistrophy, long-term critical illness, chronic fatigue syndrome, bone fracture repair | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-08-10 | — | — | US | claimed |
| US-20080108649-A1 | BICYCLIC MODULATORS OF ANDROGEN RECEPTOR FUNCTION | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-05-08 | — | — | US | claimed |
| US-5169853-A | Antibacterial agents; administering to mammals for infection | STERLING DRUG INC. (US) | 1992-12-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210068395-A1 | METHODS OF APPLYING ONE OR MORE CERTAIN HETEROARYL-1,2,4-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS TO CONTROL DAMAGE ON PLANTS, PROPAGATION MATERIAL THEREOF, AND PLANT DERIVED PRODUCTS | MT-CO2, CYP4Z1, MT-CO3 | HSP90AA1 1980/4885HSP90AB1 2022/4885TRPV4 4053/4885 |
| US-20200404919-A1 | USE OF HETEROARYL-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS AS PESTICIDES IN PLANT PROTECTION | CYP3A43, TCOF1, TARS2 | HSP90AA1 2795/4885HSP90AB1 2896/4885TRPV4 3400/4885 |
| US-10287276-B2 | Heteroaryl-1,2,4-triazole and heteroaryl-tetrazole compounds for controlling ectoparasites | CBR3, HRH4, H1-5 | HSP90AA1 4076/4885HSP90AB1 4130/4885TRPV4 2183/4885 |
| US-20140228386-A1 | 17a-HYDROXYLASE/C17,20-LYASE INHIBITORS | CYP17A1, CYP21A2, HSD17B1 | HSP90AA1 2777/4885HSP90AB1 2146/4885TRPV4 4769/4885 |
| US-20080108649-A1 | BICYCLIC MODULATORS OF ANDROGEN RECEPTOR FUNCTION | AR, ESRRA, SHBG | HSP90AA1 1836/4885HSP90AB1 1901/4885TRPV4 2315/4885 |
| US-20180186778-A1 | HETEROARYL-1,2,4-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS FOR CONTROLLING ECTOPARASITES | CBR3, HRH4, H1-5 | HSP90AA1 4076/4885HSP90AB1 4130/4885TRPV4 2183/4885 |
| US-20110118319-A1 | Insecticidal Arylpyrroline Compounds | DDT, LAP3, CYP4X1 | HSP90AA1 1073/4885HSP90AB1 1734/4885TRPV4 1316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.